Quick Comparison
| CDP-Choline | Ginkgo Biloba | |
|---|---|---|
| Half-Life | 56-71 hours (long elimination half-life) | 3-10 hours (varies by constituent) |
| Typical Dosage | Standard: 250-500 mg daily in 1-2 doses. Clinical (stroke/cognitive decline): 500-2000 mg daily. Most nootropic users find 250-500 mg sufficient. | Standard: 120-240 mg daily of standardized extract (24% flavone glycosides, 6% terpene lactones). EGb 761 is the most studied form. Often taken in 2-3 divided doses. |
| Administration | Oral (capsules, tablets). Very well-absorbed with nearly 100% oral bioavailability. | Oral (capsules, tablets, liquid extract). Standardized extract recommended over raw leaves. |
| Research Papers | 10 papers | 9 papers |
| Categories |
Mechanism of Action
CDP-Choline
CDP-Choline is hydrolyzed by nucleotidases and phosphatases into choline and cytidine after oral ingestion. Choline enters the acetylcholine synthesis pathway via choline acetyltransferase. Cytidine is phosphorylated to CTP and converted to uridine monophosphate (UMP), which enters the Kennedy pathway and stimulates the synthesis of phosphatidylcholine via the enzyme CTP:phosphocholine cytidylyltransferase — phosphatidylcholine is a critical component of neuronal cell membranes and synaptic vesicles. This dual mechanism simultaneously boosts neurotransmitter production and repairs membrane damage from oxidative stress or ischemia. CDP-Choline also increases dopamine D2 receptor density in the striatum and enhances dopamine release. It may modulate glutamate excitotoxicity and support mitochondrial function.
Ginkgo Biloba
Ginkgo biloba extract (EGb 761) contains flavonoids (quercetin, kaempferol, isorhamnetin) and terpenoids (ginkgolides A, B, C, J and bilobalide). The flavonoids are potent antioxidants that scavenge superoxide, hydroxyl radicals, and peroxynitrite, and protect neurons from oxidative damage; they may also chelate iron. The terpenoids (ginkgolides and bilobalide) improve blood flow by antagonizing platelet-activating factor (PAF) at the PAF receptor, which reduces platelet aggregation, blood viscosity, and improves microcirculation in the brain. Bilobalide protects mitochondria and reduces apoptosis. Ginkgo modulates nitric oxide (NO) availability via endothelial nitric oxide synthase (eNOS) for vasodilation. It inhibits monoamine oxidase A and B (MAO-A, MAO-B), mildly elevating dopamine and serotonin. It may enhance cholinergic transmission and reduce amyloid aggregation.
Risks & Safety
CDP-Choline
Common
Headache, nausea, diarrhea, insomnia.
Serious
Very safe — extensive clinical safety data.
Rare
Blurred vision, chest pain, allergic reactions.
Ginkgo Biloba
Common
Headache, dizziness, gastrointestinal discomfort, allergic skin reactions.
Serious
Increased bleeding risk — do not combine with blood thinners (warfarin, aspirin) or take before surgery.
Rare
Seizures (particularly with raw seeds, not standardized extract), severe allergic reactions.
Full Profiles
CDP-Choline →
Also known as Citicoline, this is a naturally occurring compound that provides both choline and cytidine (which converts to uridine in the body). This dual action supports both acetylcholine synthesis and cell membrane repair, making it both a cognitive enhancer and a neuroprotectant. Prescribed in many countries for stroke recovery and cognitive decline.
Ginkgo Biloba →
One of the oldest living tree species on Earth, used in traditional Chinese medicine for millennia. Ginkgo extract (EGb 761) is one of the most prescribed herbal medicines in Europe for cognitive decline and cerebrovascular insufficiency. It improves cerebral blood flow, has antioxidant properties, and modulates neurotransmitter systems. Most effective in older adults with declining cognitive function.